Search research articles
Contact Us
Filters
Showing results (131-140 of 179) with videos related to
Page
of 18
Sort By:
European Journal of Medical Research
|
April 14, 2011
The rainbow cohort: 96 week follow-up of saquinavir-containing regimens in previously antiretroviral therapy (ART)-naive and pre-treated but protease inhibitor (PI)-naive HIV-infected patients
H Knechten, C Stephan, F A Mosthaf, et al.
British Journal of Cancer
|
September 11, 2008
GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics
G Kristiansen, F R Fritzsche, K Wassermann, et al.
Brazilian Journal of Biology = Revista Brasleira De Biologia
|
February 19, 2008
Record of Rhabdostyla chironomi Kahl, 1933 (Ciliophora, Peritrichia) Epibiont on Chironomidae larvae (Diptera, Chironomidae) in a lotic sytem in Brazil
R J P Dias, A F Cabral, N N C Stephan, et al.
Medical Microbiology and Immunology
|
August 24, 2014
Improved virological and immunological efficacy of resistance-guided switch in antiretroviral therapy: a Frankfurt HIV cohort analysis
T Wolf, B Fuß, P Khaykin, et al.
Journal of Biomolecular Screening
|
February 24, 2012
Agents that stabilize mutated von Hippel-Lindau (VHL) protein: results of a high-throughput screen to identify compounds that modulate VHL proteostasis
Zhiyong Ding, Peter German, Shanshan Bai, et al.
British Journal of Cancer
|
January 24, 2008
Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
W Weichert, A Röske, V Gekeler, et al.
International Journal of Cancer
|
July 31, 2001
Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 microg/L: are they useful tools for early detection and screening of prostate cancer?
K Jung, C Stephan, U Elgeti, et al.
Journal of Biomolecular Screening
|
February 15, 2014
Identification and Characterization of Separase Inhibitors (Sepins) for Cancer Therapy
Nenggang Zhang, Kathleen Scorsone, Gouqing Ge, et al.
HIV Medicine
|
September 1, 2007
A standardized, comprehensive magnetic resonance imaging protocol for rapid and precise quantification of HIV-1-associated lipodystrophy
M Bickel, J Eisen, C Stephan, et al.
HIV Medicine
|
July 5, 2018
Similar long-term efficacy of dual therapy containing raltegravir and a boosted protease inhibitor versus standard triple therapies in pretreated HIV-1-infected patients in a retrospective, real-life cohort of 14 years
I Krznaric, M Bickel, A Carganico, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 179) with videos related to
Sort By:
Page
of 18
European Journal of Medical Research
|
April 14, 2011
The rainbow cohort: 96 week follow-up of saquinavir-containing regimens in previously antiretroviral therapy (ART)-naive and pre-treated but protease inhibitor (PI)-naive HIV-infected patients
H Knechten, C Stephan, F A Mosthaf, et al.
British Journal of Cancer
|
September 11, 2008
GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics
G Kristiansen, F R Fritzsche, K Wassermann, et al.
Brazilian Journal of Biology = Revista Brasleira De Biologia
|
February 19, 2008
Record of Rhabdostyla chironomi Kahl, 1933 (Ciliophora, Peritrichia) Epibiont on Chironomidae larvae (Diptera, Chironomidae) in a lotic sytem in Brazil
R J P Dias, A F Cabral, N N C Stephan, et al.
Medical Microbiology and Immunology
|
August 24, 2014
Improved virological and immunological efficacy of resistance-guided switch in antiretroviral therapy: a Frankfurt HIV cohort analysis
T Wolf, B Fuß, P Khaykin, et al.
Journal of Biomolecular Screening
|
February 24, 2012
Agents that stabilize mutated von Hippel-Lindau (VHL) protein: results of a high-throughput screen to identify compounds that modulate VHL proteostasis
Zhiyong Ding, Peter German, Shanshan Bai, et al.
British Journal of Cancer
|
January 24, 2008
Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
W Weichert, A Röske, V Gekeler, et al.
International Journal of Cancer
|
July 31, 2001
Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 microg/L: are they useful tools for early detection and screening of prostate cancer?
K Jung, C Stephan, U Elgeti, et al.
Journal of Biomolecular Screening
|
February 15, 2014
Identification and Characterization of Separase Inhibitors (Sepins) for Cancer Therapy
Nenggang Zhang, Kathleen Scorsone, Gouqing Ge, et al.
HIV Medicine
|
September 1, 2007
A standardized, comprehensive magnetic resonance imaging protocol for rapid and precise quantification of HIV-1-associated lipodystrophy
M Bickel, J Eisen, C Stephan, et al.
HIV Medicine
|
July 5, 2018
Similar long-term efficacy of dual therapy containing raltegravir and a boosted protease inhibitor versus standard triple therapies in pretreated HIV-1-infected patients in a retrospective, real-life cohort of 14 years
I Krznaric, M Bickel, A Carganico, et al.
Page
of 18